INVO Bioscience, Inc.

• locale

  United States

• market

  STOCKS

• industry

  Medical - Devices

• website

  www.invobio.com

• ipo date

  Nov 02, 2020

INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

*Estimate based on analyst consensus